Related Experiment Video
Updated: Dec 25, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
3.2K
Coronaviruses and SARS-CoV-2: A Brief Overview.
Stephan Ludwig1, Alexander Zarbock2
1From the Institute of Molecular Virology (IMV), University Hospital Münster, Münster, Germany.
Anesthesia and Analgesia
|April 4, 2020
Summary
A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), caused the COVID-19 pandemic. This review details SARS-CoV-2 and explores potential therapies for coronavirus disease 2019.
Area of Science:
- Virology
- Infectious Diseases
- Public Health
Background:
- Emergence of a novel coronavirus, SARS-CoV-2, in late 2019.
- Identification of SARS-CoV-2 as the causative agent of COVID-19.
- Global spread leading to a WHO-declared pandemic in March 2020.
Purpose of the Study:
- Provide background on coronaviruses.
- Detail the novel SARS-CoV-2.
- Describe efforts to find effective COVID-19 therapies.
Main Methods:
- Literature review of coronavirus background.
- Detailed description of SARS-CoV-2.
- Summary of therapeutic strategies for COVID-19.
Main Results:
- Coronaviruses are a known family of viruses.
- SARS-CoV-2 is a specific novel strain responsible for the pandemic.
- Ongoing research into various therapeutic interventions.
Conclusions:
- Understanding SARS-CoV-2 is crucial for pandemic response.
- Development of effective therapies is a priority.
- Continued research is essential to combat COVID-19.
Related Concept Videos
00:50What are Viruses?
127.1K
Overview
127.1K
01:28Introduction to Virus
976
Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
976
01:29Viruses with RNA Genomes
605
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
605
01:03Rous Sarcoma Virus (RSV) and Cancer
6.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.0K
00:36Viral Mutations
39.4K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.4K
01:05Single Nucleotide Polymorphisms-SNPs
17.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K